"Global Liver Cirrhosis Market 2016-2020" is now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Thu May 19 2016

Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.

Technavio's analysts forecast the global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.

Full Report Details at
- http://www.fastmr.com/prod/1171606_global_liver_cirrhosis.aspx?afid=302

The market is divided into the following segments based on geography:

* Americas

Technavio's report, Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* F Hoffman La-Roche
* GlaxoSmithKline
* Gilead Sciences
* Johnson & Johnson
* Merck

Other prominent vendors

* Bristol-Myers Squibb
* Conatus Pharmaceuticals
* Gwo Xi Stem Cell Applied Technology
* Instituto Grifols
* Intercept Pharmaceuticals
* NGM Biopharmaceuticals
* Norgine
* Pharmicell
* Salix Pharmaceuticals
* Stempeutics Research

Market driver

* High prevalence of liver cirrhosis
* For a full, detailed list, view our report

Market challenge

* Adverse effects of drugs
* For a full, detailed list, view our report

Market trend

* Use of off-label drugs
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2020 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Liver Cirrhosis Global Clinical Trials Review, H1, 2016
- Global Liver Diseases Therapeutics Market 2015-2019
- Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015
- Chronic Liver Disease Global Clinical Trials Review, H1, 2015
- Liver Fibrosis Global Clinical Trials Review, H1, 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »